Bristol-Myers Squibb GmbH & Co. KGaA
Industry / private company
Location:
München,
Germany (DE)
ISNI: -
ROR: https://ror.org/032hfv632
Show on Map:
The Effectiveness of Patient Training in Inflammatory Bowel Disease Knowledge via Instagram: Randomized Controlled Trial (2022)
Blunck D, Kastner L, Nissen M, Winkler J
Journal article, Original article
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020)
Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al.
Journal article
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy (2019)
Renner K, Bruss C, Schnell A, Koehl G, Becker HM, Fante M, Menevse AN, et al.
Journal article
A simplified approach to determine effective surface area and porosity of low bulk density active pharmaceutical ingredients in early development. (2015)
Sharif S, Dimemmo LM, Thommes M, Hubert M, Sarsfield BA
Journal article, Original article
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment (2013)
Clerx L, Van Rossum IA, Burns L, Knol DL, Scheltens P, Verhey F, Aalten P, et al.
Journal article